Inhibikase Therapeutics, Inc. Property, Plant and Equipment
Inhibikase Therapeutics, Inc. (IKT) had Property, Plant and Equipment of $0 as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-03-26
- 2025-12-31: Property, Plant and Equipment, Net $0.00.
- 2025-09-30: Property, Plant and Equipment, Net $0.00.
- 2025-06-30: Property, Plant and Equipment, Net $23.69K.
- 2025-03-31: Property, Plant and Equipment, Net $47.84K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $23.69K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $47.84K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $47.10K 10-K · filed 2026-03-26 |
| 2024-09-30 | $53.67K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $60.23K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $66.80K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $73.37K 10-K · filed 2025-03-27 |
| 2023-09-30 | $79.94K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $86.52K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $231.49K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $236.53K 10-K · filed 2024-03-27 |
| 2022-09-30 | $241.57K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $43.09K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |